SEC Form 4 · accession 0001053310-18-000001
INTEGRATED BIOPHARMA INC · INBP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
E Gerald Kay
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Dec 19, 2018
Accepted (ET)
Dec 19, 2018 · 6:45 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001016504
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 19, 2018 | A | 100,000 | $0.10 | A | 5,262,556 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1100,000 common stock shares acquired upon exercise of stock option grant dated June 2, 2015.